Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS
· Delayed Price · Currency is USD
12.75
0.00 (0.00%)
Apr 23, 2025, 11:17 AM EDT
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $20.31 million as of April 23, 2025. Its market cap has increased by 270.07% in one year.
Market Cap
20.31M
Enterprise Value
33.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.75
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 20.31M, a decrease of -97.98%. That is a compound annual growth rate of -61.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 20.31M | 11.95% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.66B |
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 704.15M |
| Elite Pharmaceuticals | 437.70M |
| Northwest Biotherapeutics | 402.62M |
| Glass House Brands | 387.66M |
| CytoDyn | 264.36M |